Member Info for aspex

FWIW UT trades seem to be from overseas brokers acting on behalf of non resident (not US) private customers. all of my recent trades have been UT.

BUT , is ELC willing to sell its product to others and particularly to Competitors?

Interesting but Croda has a very broad market reach.

Have always seen these as a takeover defence because for any bid to succeed these options are part of the hurdle of 90%

Well there is the way to publicise the product.

Lesson there for Slimbiome and GoFigure. .???

My opinion is that once Elrico had decided he had new or extended views from SOH it obliged him to make the interview public. That is his decision and he did the right thing.

On 20 August we have the comment that product had been made for use with a large global partner.

So well over three months on are we likely to get that major reveal?

Rather sell off some PBX than SBTX.

Oleric,

That assumes NovoNordisk have the clout of their IP to prevent it.

Sure they can specify the original regime but if Opti or someone else offers something to carry on the result that is another matter entirely.

Has he been taking more than the P.M.?

I assume we can conclude that is a “definite maybe” then.

SOH needs to contract into Quarterly reporting within the 30 days of the following month ( remember thoughts of going after a Nasdaq listing :-) )

It is understandable that up to now this would have been an embarrassment but surely the breath of customers and markets now covered would help.

Maybe as soon as Sweetbiotix gets going.

Warts and all can sometimes be the way to go!

Off to the races with some great publicity including on the back of Ozempic.

That article shows just how hollow are the ‘promises’ of Management.

Even allowing for Covid and Brexit turmoil there can now be no reasonable excuse.

SOH should have had the ammunition ready and waiting for this latest price surge.

So where is the publicity that could double the current share price?

And do we have to again wait to the very last days for progress for H1 2024?

No dispute that Ozempic does a job over a broad spectrum of functions.

The problems seem to be from lack of control of dosage or understanding of application.

As pointed out where a patient has achieved a desired weight there is a case for transferring to a product like Slimbiome that is both cheaper, less invasive and controllable by the user.

.

Just needs great marketing!

Thanks martinu.

I had seen that and what I thought was anybody that has the money to get on to Ozempic would have the initial desire to get weight off but after that ‘burst’ of weight loss could then avoid the injections and the potential hazards of longer term use by moving on to Slimbiome for holding the benefits.

Surely SOH could find a way to persuade them.

Been listening to Johann Hari about Ozempic .

He emphasised that Ozempic works BUT the long term risks are very significant.

It may be time for Optibiotix to offer a longer term EXTENSION using Slimbiome/ Wellbiome to both reduce the ONGOING COSTS and the SIGNIFICANT FUTURE HEALTH/LIFE RISKS evident from current knowledge.

Get SOH on to it right now.

Well there is very little of the Yorkshire fund if any to support him, so he is in a much weaker position than previously.

IMO SOH needs to provide a taster or two in the form of announcement to the market prior to the meet in order to have something of worth.

SweetBiotix progress would be nice or

transfer of PBX to AIM to make it marketable

This deal looks impressive on the surface.

Question is how much revenue from sales this will provide for Opti from royalties etc.

The thing that surprised me the most is that SOH who is a decent type has been so gullible to associate himself with the TW rubbish machine and has not yet divorced himself.

While I accept the Covid affected everything we should be in a much better place by now.

The missing link IMHO was not raising capital when the share price was over a quid. That was a SOH ego trip by not wishing to dilute his capital.

I am offended by the paycheque that SOH has continued to extract well beyond any excuses to justify it.